Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports

The advent of intra-nasal esketamine (ESK), one of the first so called fast-acting antidepressant, promises to revolutionize the management of treatment resistant depression (TRD). This NMDA receptor antagonist has proven to be rapidly effective in the short- and medium-term course of the illness, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcatili, Matteo, Borgonovo, Riccardo, Cimminiello, Noemi, Cornaggia, Ranieri Domenico, Casati, Giulia, Pellicioli, Cristian, Maggioni, Laura, Motta, Federico, Redaelli, Chiara, Ledda, Luisa, Pozzi, Federico Emanuele, Krivosova, Michaela, Pagano, Jessica, Nava, Roberto, Colmegna, Fabrizia, Dakanalis, Antonios, Caldiroli, Alice, Capuzzi, Enrico, Benatti, Beatrice, Dell’Osso, Bernardo, Bertola, Francesca, Villa, Nicoletta, Piperno, Alberto, Ippolito, Silvia, Appollonio, Ildebrando, Sala, Carlo, Conti, Luciano, Clerici, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503866/
https://www.ncbi.nlm.nih.gov/pubmed/36143309
http://dx.doi.org/10.3390/jpm12091524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503866/
https://www.ncbi.nlm.nih.gov/pubmed/36143309
http://dx.doi.org/10.3390/jpm12091524

Ejemplares similares